Epitelial-to-mesenchimal transition and invasion are upmodulated by tumor-expressed granzyme B and inhibited by docosahexaenoic acid in human colorectal cancer cells

Por D’Eliseo, Donatella, Di Rocco, Giuliana, Loria, Rossella, Soddu, Silvia, Santoni, Angela, Velotti, Francesca
Publicado no J Exp Clin Cancer Res (2016)

Prognostic role of NF-YA splicing isoforms and Lamin A status in low grade endometrial cancer

Por Cicchillitti, Lucia, Corrado, Giacomo, Carosi, Mariantonia, Dabrowska, Malgorzata Ewa, Loria, Rossella, Falcioni, Rita, Cutillo, Giuseppe, Piaggio, Giulia, Vizza, Enrico
Publicado no Oncotarget (2016)

Very low intensity ultrasounds as a new strategy to improve selective delivery of nanoparticles-complexes in cancer cells

Por Loria, Rossella, Giliberti, Claudia, Bedini, Angelico, Palomba, Raffaele, Caracciolo, Giulio, Ceci, Pierpaolo, Falvo, Elisabetta, Marconi, Raffaella, Falcioni, Rita, Bossi, Gianluca, Strigari, Lidia
Publicado no J Exp Clin Cancer Res (2019)

Endometrial cancer prognosis correlates with the expression of L1CAM and miR34a biomarkers

Por Corrado, Giacomo, Laquintana, Valentina, Loria, Rossella, Carosi, Mariantonia, de Salvo, Laura, Sperduti, Isabella, Zampa, Ashanti, Cicchillitti, Lucia, Piaggio, Giulia, Cutillo, Giuseppe, Falcioni, Rita, Vizza, Enrico
Publicado no J Exp Clin Cancer Res (2018)

Sema6A and Mical1 control cell growth and survival of BRAF(V600E) human melanoma cells

Por Loria, Rossella, Bon, Giulia, Perotti, Valentina, Gallo, Enzo, Bersani, Ilaria, Baldassari, Paola, Porru, Manuela, Leonetti, Carlo, Di Carlo, Selene, Visca, Paolo, Brizzi, Maria Felice, Anichini, Andrea, Mortarini, Roberta, Falcioni, Rita
Publicado no Oncotarget (2014)

Dual targeting of HER3 and MEK may overcome HER3-dependent drug-resistance of colon cancers

Por Bon, Giulia, Loria, Rossella, Amoreo, Carla Azzurra, Verdina, Alessandra, Sperduti, Isabella, Mastrofrancesco, Arianna, Soddu, Silvia, Diodoro, Maria Grazia, Mottolese, Marcella, Todaro, Matilde, Stassi, Giorgio, Milella, Michele, De Maria, Ruggero, Falcioni, Rita
Publicado no Oncotarget (2016)

HMGA1/E2F1 axis and NFkB pathways regulate LPS progression and trabectedin resistance

Por Loria, Rossella, Laquintana, Valentina, Bon, Giulia, Trisciuoglio, Daniela, Frapolli, Roberta, Covello, Renato, Amoreo, Carla Azzurra, Ferraresi, Virginia, Zoccali, Carmine, Novello, Mariangela, Del Bufalo, Donatella, Milella, Michele, Biagini, Roberto, D’Incalci, Maurizio, Falcioni, Rita
Publicado no Oncogene (2018)

H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer

Por Bacci, Lorenza, Aiello, Aurora, Ripoli, Cristian, Loria, Rossella, Pugliese, Dario, Pierconti, Francesco, Rotili, Dante, Strigari, Lidia, Pinto, Francesco, Bassi, Pier Francesco, Mai, Antonello, Grassi, Claudio, Pontecorvi, Alfredo, Falcioni, Rita, Farsetti, Antonella, Nanni, Simona
Publicado no Int J Mol Sci (2019)

Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group

Por Racanelli, Dominga, Brenca, Monica, Baldazzi, Davide, Goeman, Frauke, Casini, Beatrice, De Angelis, Biagio, Guercio, Marika, Milano, Giuseppe Maria, Tamborini, Elena, Busico, Adele, Dagrada, Gianpaolo, Garofalo, Cecilia, Caruso, Chiara, Brunello, Antonella, Pignochino, Ymera, Berrino, Enrico, Grignani, Giovanni, Scotlandi, Katia, Parra, Alessandro, Hattinger, Claudia Maria, Ibrahim, Toni, Mercatali, Laura, De Vita, Alessandro, Carriero, Maria Vincenza, Pallocca, Matteo, Loria, Rossella, Covello, Renato, Sbaraglia, Marta, Dei Tos, Angelo Paolo, Falcioni, Rita, Maestro, Roberta
Publicado no Front Oncol (2020)

Corrigendum: Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group

Por Racanelli, Dominga, Brenca, Monica, Baldazzi, Davide, Goeman, Frauke, Casini, Beatrice, De Angelis, Biagio, Guercio, Marika, Milano, Giuseppe Maria, Tamborini, Elena, Busico, Adele, Dagrada, Gianpaolo, Garofalo, Cecilia, Caruso, Chiara, Brunello, Antonella, Pignochino, Ymera, Berrino, Enrico, Grignani, Giovanni, Scotlandi, Katia, Parra, Alessandro, Hattinger, Claudia Maria, Ibrahim, Toni, Mercatali, Laura, De Vita, Alessandro, Carriero, Maria Vincenza, Pallocca, Matteo, Loria, Rossella, Covello, Renato, Sbaraglia, Marta, Dei Tos, Angelo Paolo, Falcioni, Rita, Maestro, Roberta
Publicado no Front Oncol (2020)

Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study

Por Bon, Giulia, Pizzuti, Laura, Laquintana, Valentina, Loria, Rossella, Porru, Manuela, Marchiò, Caterina, Krasniqi, Eriseld, Barba, Maddalena, Maugeri-Saccà, Marcello, Gamucci, Teresa, Berardi, Rossana, Livi, Lorenzo, Ficorella, Corrado, Natoli, Clara, Cortesi, Enrico, Generali, Daniele, La Verde, Nicla, Cassano, Alessandra, Bria, Emilio, Moscetti, Luca, Michelotti, Andrea, Adamo, Vincenzo, Zamagni, Claudio, Tonini, Giuseppe, Barchiesi, Giacomo, Mazzotta, Marco, Marinelli, Daniele, Tomao, Silverio, Marchetti, Paolo, Valerio, Maria Rosaria, Mirabelli, Rosanna, Russo, Antonio, Fabbri, Maria Agnese, D’Ostilio, Nicola, Veltri, Enzo, Corsi, Domenico, Garrone, Ornella, Paris, Ida, Sarobba, Giuseppina, Giotta, Francesco, Garufi, Carlo, Cazzaniga, Marina, Del Medico, Pietro, Roselli, Mario, Sanguineti, Giuseppe, Sperduti, Isabella, Sapino, Anna, De Maria, Ruggero, Leonetti, Carlo, Di Leo, Angelo, Ciliberto, Gennaro, Falcioni, Rita, Vici, Patrizia
Publicado no J Exp Clin Cancer Res (2020)